Skip to main content
FutureChem Co., Ltd. logo

FutureChem Co., Ltd. — Investor Relations & Filings

Ticker · 220100 ISIN · KR7220100002 KO Manufacturing
Open in API
Filings indexed 312 across all filing types
Latest filing 2019-03-04 Proxy Solicitation & In…
Country KR South Korea
Listing KO 220100

About FutureChem Co., Ltd.

https://www.futurechem.co.kr/?language=…

FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company FutureChem. It outlines the date, location, agenda items (including financial statement approval, director appointments, and remuneration limits), and details regarding the board's decision. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting details and request their participation/votes.
2019-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (FutureChem) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report preliminary financial results before the final audit report is finalized. Since it provides key financial highlights and reasons for the change, it falls under the Earnings Release (ER) category.
2019-02-25 Korean
투자판단관련주요경영사항(알자뷰주사액 기술이전 계약체결)
M&A Activity Classification · 95% confidence The document is a regulatory announcement from FutureChem regarding a technology transfer agreement (licensing deal) for their product 'Alzavue' in Turkey. It details the counterparty, contract terms, and financial implications (milestones/royalties). This type of corporate disclosure regarding business development and material contracts is classified as a Regulatory Filing (RNS) as it does not fit into specific categories like M&A (which usually implies corporate mergers/acquisitions) or other specialized financial reports.
2018-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal notice of a corporate action related to meeting preparation. Given the nature of the announcement and its brevity, it falls under the category of general regulatory filings.
2018-12-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure of insider trading activities (purchases/sales of shares by directors or major shareholders). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2018-12-07 Korean
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. It is not the presentation itself, but rather a notification of the event and the availability of materials. According to the 'Menu vs Meal' rule, announcements of events or reports are classified as Report Publication Announcements (RPA) or Regulatory Filings (RNS). Given the specific nature of the announcement regarding an IR event, it fits best as a Regulatory Filing (RNS) or an announcement of an event.
2018-12-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.